tallimustine has been researched along with Leukemia L 1210 in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (85.71) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ballinari, D; Broggini, M; D'Incalci, M; Erba, E; Geroni, C; Grandi, M; Mongelli, N; Pesenti, E; Spreafico, F; Tagliabue, G | 1 |
| Capolongo, L; Ciomei, M; Geroni, C; Grandi, M; Melegaro, G; Pastori, W; Pennella, G | 1 |
| D'Incalci, M; Filippini, C; Tagliabue, G; Ubezio, P | 1 |
| Animati, F; Bigioni, M; Lombardi, P; Manzini, S; Palma, C; Pratesi, G; Salvatore, C; Supino, R; Zunino, F | 1 |
| Beria, I; Broggini, M; Capolongo, L; Cozzi, P; D'Incalci, M; Geroni, C; Marchini, S | 1 |
| Balboni, G; Baraldi, PG; Bianchi, N; Cozzi, P; Gambari, R; Geroni, C; Mongelli, N; Romagnoli, R; Rutigliano, C; Spalluto, G | 1 |
| Baraldi, PG; Bianchi, N; Cozzi, P; Gambari, R; Mongelli, N; Romagnoli, R; Spalluto, G | 1 |
7 other study(ies) available for tallimustine and Leukemia L 1210
| Article | Year |
|---|---|
Establishment of L1210 leukemia cells resistant to the distamycin-A derivative (FCE 24517): characterization and cross-resistance studies.
Topics: Animals; Antineoplastic Agents; Buthionine Sulfoximine; Cell Cycle; Cell Separation; Distamycins; Drug Resistance; Female; Glutathione; Leukemia L1210; Methionine Sulfoximine; Mice; Mice, Inbred DBA; Neoplasm Transplantation; Nitrogen Mustard Compounds; Tumor Cells, Cultured | 1993 |
Decreased tyrosine phosphorylation in tumour cells resistant to FCE 24517 (tallimustine).
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Colonic Neoplasms; Distamycins; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Enzyme Inhibitors; Humans; Leukemia L1210; Mice; Neoplasm Proteins; Nitrogen Mustard Compounds; Phosphorylation; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Sensitivity and Specificity; Tumor Cells, Cultured; Tyrosine; Vanadates | 1995 |
Combination of the new minor groove alkylator tallimustine and melphalan.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Distamycins; Female; Leukemia L1210; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Neoplasm Transplantation; Nitrogen Mustard Compounds; Ovarian Neoplasms; Survival Rate | 1997 |
Cytotoxic and antitumor activity of MEN 10710, a novel alkylating derivative of distamycin.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Calcium Channel Blockers; Cell Survival; Distamycins; Humans; Leukemia L1210; Melphalan; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Neoplastic Stem Cells; Nitrogen Mustard Compounds; Organ Size; Tumor Cells, Cultured; Verapamil | 1997 |
Sequence-specific DNA alkylation of novel tallimustine derivatives.
Topics: Animals; Antineoplastic Agents, Alkylating; Autoradiography; Distamycins; DNA; DNA Footprinting; Electrophoresis, Agar Gel; Humans; Leukemia L1210; Nitrogen Mustard Compounds; Tumor Cells, Cultured | 1998 |
PNU 157977: a new potent antitumour agent exhibiting low in vivo toxicity in mice injected with L1210 leukaemia cells.
Topics: Animals; Antineoplastic Agents, Alkylating; Cell Survival; Distamycins; DNA Footprinting; Drug Design; Leukemia L1210; Mice; Neoplasm Transplantation; Nitrogen Mustard Compounds; Receptors, Estrogen; Reverse Transcriptase Polymerase Chain Reaction; Structure-Activity Relationship; Tumor Cells, Cultured | 1999 |
DNA sequence-recognizing properties of minor groove alkylating agents. Effects of the replacement of N-methylpyrrole by an N-methylimidazole on tallimustine and its own homologue.
Topics: Animals; Antineoplastic Agents, Alkylating; Distamycins; DNA; DNA Primers; Female; Genes, ras; Humans; Imidazoles; Leukemia L1210; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Nitrogen Mustard Compounds; Polymerase Chain Reaction; Pyrroles; Receptors, Estrogen; Structure-Activity Relationship | 2000 |